Therefore, our findings not only contribute to a deeper understanding of the role of IGFBP2 in HCC but also have the potential to serve as a valuable tool for predicting metastasis risk in HCC patients with high IGFBP2 expression levels (Fig. 5). This evidence concerns the gene IGFBP2 and hepatocellular carcinoma.